Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 1,299 | 1,614 | 1,950 | 20,558 | 37,398 |
| Gross Profit | 1,299 | 1,614 | 1,950 | 20,558 | 37,398 |
| Operating Expenses | 43,507 | 48,665 | 48,799 | 42,348 | 43,265 |
| Operating Income | -42,208 | -47,051 | -46,849 | -21,790 | -5,867 |
| Other Income | 3,136 | 3,571 | 3,924 | 4,441 | 5,128 |
| Pre-tax Income | -39,072 | -43,480 | -42,925 | -17,349 | -739 |
| Income Tax | 92 | 654 | 178 | N/A | -1,870 |
| Net Income Continuous | -39,164 | -44,134 | -43,103 | -17,349 | 1,131 |
| Net Income | $-39,164 | $-44,134 | $-43,103 | $-17,349 | $1,131 |
| EPS Basic Total Ops | -0.95 | -1.06 | -1.04 | -0.42 | -0.20 |
| EPS Basic Continuous Ops | -0.95 | -1.06 | -1.04 | -0.42 | -0.21 |
| EPS Diluted Total Ops | -0.95 | -1.06 | -1.04 | -0.42 | -0.20 |
| EPS Diluted Continuous Ops | -0.95 | -1.06 | -1.04 | -0.42 | -0.20 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.06 | -1.04 | -0.42 | 0.03 |
| EBITDA(a) | $-41,955 | $-46,560 | $-46,776 | $-22,182 | $-7,382 |